Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Research & Development: 2023-2025

Historic Research & Development for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $33.0 million.

  • Upstream Bio's Research & Development rose 113.67% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.4 million, marking a year-over-year increase of 124.49%. This contributed to the annual value of $63.0 million for FY2024, which is 98.01% up from last year.
  • Upstream Bio's Research & Development amounted to $33.0 million in Q3 2025, which was down 12.91% from $37.9 million recorded in Q2 2025.
  • Upstream Bio's Research & Development's 5-year high stood at $37.9 million during Q2 2025, with a 5-year trough of $7.8 million in Q3 2023.
  • Moreover, its 3-year median value for Research & Development was $15.4 million (2024), whereas its average is $19.9 million.
  • Data for Upstream Bio's Research & Development shows a peak YoY soared of 169.14% (in 2025) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Research & Development (Quarterly) stood at $11.6 million in 2023, then soared by 88.45% to $21.8 million in 2024, then skyrocketed by 113.67% to $33.0 million in 2025.
  • Its Research & Development was $33.0 million in Q3 2025, compared to $37.9 million in Q2 2025 and $25.8 million in Q1 2025.